|
1
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar
|
|
2
|
Hong W and Dong E: The past, present and
future of breast cancer research in China. Cancer Lett. 351:1–5.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Berse B and Lynch JA: Molecular diagnostic
testing in breast cancer. Semin Oncol Nurs. 31:108–121. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guo H, Ingolia NT, Weissman JS and Bartel
DP: Mammalian microRNAs predominantly act to decrease target mRNA
levels. Nature. 466:835–840. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar :
|
|
9
|
Tang J, Ahmad A and Sarkar FH: The role of
microRNAs in breast cancer migration, invasion and metastasis. Int
J Mol Sci. 13:13414–13437. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Christodoulatos GS and Dalamaga M:
Micro-RNAs as clinical biomarkers and therapeutic targets in breast
cancer: Quo vadis? World J Clin Oncol. 5:71–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schrauder MG, Strick R, Schulz-Wendtland
R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A,
Hein A, et al: Circulating micro-RNAs as potential blood-based
markers for early stage breast cancer detection. PLoS One.
7:e297702012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Le Quesne J and Caldas C: Micro-RNAs and
breast cancer. Mol Oncol. 4:230–241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang XH, Chen JS, Wang Q, Chen XL, Wen L,
Chen LZ, Bi J, Zhang LJ, Su Q and Zeng WT: miR-338–3p suppresses
invasion of liver cancer cell by targeting smoothened. J Pathol.
225:463–472. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fu X, Tan D, Hou Z, Hu Z, Liu G, Ouyang Y
and Liu F: The effect of miR-338-3p on HBx deletion-mutant
(HBx-d382) mediated liver-cell proliferation through CyclinD1
regulation. PLoS One. 7:e432042012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen X, Pan M, Han L, Lu H, Hao X and Dong
Q: miR-338-3p suppresses neuroblastoma proliferation, invasion and
migration through targeting PREX2a. FEBS Lett. 587:3729–3737. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wen C, Liu X, Ma H, Zhang W and Li H:
miR-338-3p suppresses tumor growth of ovarian epithelial carcinoma
by targeting Runx2. Int J Oncol. 46:2277–2285. 2015.PubMed/NCBI
|
|
17
|
Caramuta S, Egyházi S, Rodolfo M, Witten
D, Hansson J, Larsson C and Lui WO: MicroRNA expression profiles
associated with mutational status and survival in malignant
melanoma. J Invest Dermatol. 130:2062–2070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li P, Chen X, Su L, Li C, Zhi Q, Yu B,
Sheng H, Wang J, Feng R, Cai Q, et al: Epigenetic silencing of
miR-338-3p contributes to tumorigenicity in gastric cancer by
targeting SSX2IP. PLoS One. 8:e667822013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo B, Liu L, Yao J, Ma R, Chang D, Li Z,
Song T and Huang C: miR-338-3p suppresses gastric cancer
progression through a PTEN-AKT axis by targeting P-REX2a. Mol
Cancer Res. 12:313–321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun K, Su G, Deng H, Dong J, Lei S and Li
G: Relationship between miRNA-338-3p expression and progression and
prognosis of human colorectal carcinoma. Chin Med J (Engl).
127:1884–1890. 2014.
|
|
21
|
Sun K, Deng HJ, Lei ST, Dong JQ and Li GX:
miRNA-338-3p suppresses cell growth of human colorectal carcinoma
by targeting smoothened. World J Gastroenterol. 19:2197–2207. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang L and Wang J: MicroRNA-mediated
breast cancer metastasis: From primary site to distant organs.
Oncogene. 31:2499–2511. 2012. View Article : Google Scholar
|
|
23
|
Kusama M, Kaise H, Nakayama S, Ohta D,
Aoki T and Koyanagi Y: A case of breast cancer patient of CAF
(cyclophosphamide, adriamycin, 5-fluorouracil) resistant lung
metastasis with remarkable response to reverse drug-resistance by
toremifene. Gan To Kagaku Ryoho. 26:1171–1175. 1999.(In Japanese).
PubMed/NCBI
|
|
24
|
Tang J, Ahmad A and Sarkar FH: The role of
microRNAs in breast cancer migration, invasion and metastasis. Int
J Mol Sci. 13:13414–13437. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin Y, Liu AY, Fan C, Zheng H, Li Y, Zhang
C, Wu S, Yu D, Huang Z, Liu F, et al: MicroRNA-33b inhibits breast
cancer metastasis by targeting HMGA2, SALL4 and Twist1. Sci Rep.
5:99952015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ahmad A, Ginnebaugh KR, Sethi S, Chen W,
Ali R, Mittal S and Sarkar FH: miR-20b is up-regulated in brain
metastases from primary breast cancers. Oncotarget. 6:12188–12195.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li W, Zhai L, Zhao C and Lv S: MiR-153
inhibits epithelial-mesenchymal transition by targeting metadherin
in human breast cancer. Breast Cancer Res Treat. 150:501–509. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yi B, Piazza GA, Su X and Xi Y: MicroRNA
and cancer chemo-prevention. Cancer Prev Res (Phila). 6:401–409.
2013. View Article : Google Scholar
|
|
29
|
Vervoort SJ, Lourenço AR, van Boxtel R and
Coffer PJ: SOX4 mediates TGF-β-induced expression of mesenchymal
markers during mammary cell epithelial to mesenchymal transition.
PLoS One. 8:e532382013. View Article : Google Scholar
|
|
30
|
Vervoort SJ, van Boxtel R and Coffer PJ:
The role of SRY-related HMG box transcription factor 4 (SOX4) in
tumorigenesis and metastasis: Friend or foe? Oncogene.
32:3397–3409. 2013. View Article : Google Scholar
|
|
31
|
Bowles J, Schepers G and Koopman P:
Phylogeny of the SOX family of developmental transcription factors
based on sequence and structural indicators. Dev Biol. 227:239–255.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song GD, Sun Y, Shen H and Li W: SOX4
overexpression is a novel biomarker of malignant status and poor
prognosis in breast cancer patients. Tumour Biol. Jan 16–2015.(Epub
ahead of print] 2015. View Article : Google Scholar
|
|
33
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
Large-scale meta-analysis of cancer microarray data identifies
common transcriptional profiles of neoplastic transformation and
progression. Proc Natl Acad Sci USA. 101:9309–9314. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Scharer CD, McCabe CD, Ali-Seyed M, Berger
MF, Bulyk ML and Moreno CS: Genome-wide promoter analysis of the
SOX4 transcriptional network in prostate cancer cells. Cancer Res.
69:709–717. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tiwari N, Tiwari VK, Waldmeier L, Balwierz
PJ, Arnold P, Pachkov M, Meyer-Schaller N, Schübeler D, van
Nimwegen E and Christofori G: Sox4 is a master regulator of
epithelial-mesenchymal transition by controlling Ezh2 expression
and epigenetic reprogramming. Cancer Cell. 23:768–783. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tavazoie SF, Alarcón C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Koumangoye RB, Andl T, Taubenslag KJ,
Zilberman ST, Taylor CJ, Loomans HA and Andl CD: SOX4 interacts
with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal
cancer cells. Mol Cancer. 14:242015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu X, Song H, Xia T, Han S, Xiao B, Luo L,
Xi Y and Guo J: Growth inhibitory effects of three miR-129 family
members on gastric cancer. Gene. 532:87–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Luo XJ, Tang DG, Gao TL, Zhang YL, Wang M,
Quan ZX and Chen J: MicroRNA-212 inhibits osteosarcoma cells
proliferation and invasion by down-regulation of Sox4. Cell Physiol
Biochem. 34:2180–2188. 2014. View Article : Google Scholar
|
|
40
|
Yeh YM, Chuang CM, Chao KC and Wang LH:
MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis
by targeting SOX4 and HIF-1α. Int J Cancer. 133:867–878. 2013.
View Article : Google Scholar : PubMed/NCBI
|
